Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)
China
· Delayed Price · Currency is CNY 46.69
+0.17 (0.37%)
At close: Dec 5, 2025
SHA:603392 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 1,765 | 2,215 | 5,493 | 11,167 | 5,702 | 2,337 | Upgrade
|
| Other Revenue | 30.31 | 30.31 | 17.3 | 18.52 | 48.34 | 17.14 | Upgrade
|
| Revenue | 1,796 | 2,245 | 5,511 | 11,185 | 5,750 | 2,354 | Upgrade
|
| Revenue Growth (YoY) | -27.88% | -59.25% | -50.73% | 94.51% | 144.25% | 98.88% | Upgrade
|
| Cost of Revenue | 937.13 | 866.34 | 1,084 | 1,198 | 850.67 | 473.6 | Upgrade
|
| Gross Profit | 858.53 | 1,379 | 4,427 | 9,987 | 4,900 | 1,881 | Upgrade
|
| Selling, General & Admin | 821.68 | 790.16 | 1,878 | 3,490 | 1,874 | 810.21 | Upgrade
|
| Research & Development | 593.87 | 874.57 | 1,177 | 1,091 | 677.42 | 309.13 | Upgrade
|
| Other Operating Expenses | 112.49 | 14.67 | 31.57 | 51.28 | 26.71 | 12.51 | Upgrade
|
| Operating Expenses | 1,568 | 1,694 | 3,063 | 4,723 | 2,662 | 1,156 | Upgrade
|
| Operating Income | -709.07 | -315.37 | 1,364 | 5,265 | 2,238 | 724.74 | Upgrade
|
| Interest Expense | -9.11 | -8.32 | -6.86 | -7.67 | -5.69 | -1.69 | Upgrade
|
| Interest & Investment Income | 109.75 | 169.09 | 186.88 | 78.26 | 21 | 18.58 | Upgrade
|
| Currency Exchange Gain (Loss) | 7.42 | 7.42 | 13.01 | 27.89 | -8.75 | -14.29 | Upgrade
|
| Other Non Operating Income (Expenses) | 15.26 | -5.77 | -1.87 | -1 | 0.05 | -0.79 | Upgrade
|
| EBT Excluding Unusual Items | -585.74 | -152.95 | 1,555 | 5,362 | 2,244 | 726.55 | Upgrade
|
| Gain (Loss) on Sale of Investments | 46.45 | 36.71 | 24.66 | 9.98 | 0.03 | 0.35 | Upgrade
|
| Gain (Loss) on Sale of Assets | 5.36 | 7.39 | -1.08 | -2.74 | -0.97 | 0.42 | Upgrade
|
| Asset Writedown | -6.31 | - | -259.15 | - | - | - | Upgrade
|
| Other Unusual Items | 169.72 | 176.33 | 73.7 | 213.42 | 80.85 | 37.13 | Upgrade
|
| Pretax Income | -370.53 | 67.48 | 1,393 | 5,583 | 2,324 | 764.45 | Upgrade
|
| Income Tax Expense | -35.24 | -41.61 | 146.89 | 719.39 | 244.93 | 82.64 | Upgrade
|
| Earnings From Continuing Operations | -335.28 | 109.09 | 1,247 | 4,863 | 2,079 | 681.82 | Upgrade
|
| Minority Interest in Earnings | 1.45 | -2.86 | 1.18 | -127.51 | -57.75 | -4.82 | Upgrade
|
| Net Income | -333.84 | 106.24 | 1,248 | 4,736 | 2,021 | 677 | Upgrade
|
| Net Income to Common | -333.84 | 106.24 | 1,248 | 4,736 | 2,021 | 677 | Upgrade
|
| Net Income Growth | - | -91.48% | -73.65% | 134.28% | 198.59% | 224.13% | Upgrade
|
| Shares Outstanding (Basic) | 1,305 | 1,328 | 1,260 | 1,250 | 1,230 | 1,195 | Upgrade
|
| Shares Outstanding (Diluted) | 1,305 | 1,328 | 1,260 | 1,250 | 1,230 | 1,195 | Upgrade
|
| Shares Change (YoY) | 3.21% | 5.37% | 0.86% | 1.55% | 2.96% | 8.71% | Upgrade
|
| EPS (Basic) | -0.26 | 0.08 | 0.99 | 3.79 | 1.64 | 0.57 | Upgrade
|
| EPS (Diluted) | -0.26 | 0.08 | 0.99 | 3.79 | 1.64 | 0.57 | Upgrade
|
| EPS Growth | - | -91.92% | -73.88% | 130.69% | 190.01% | 198.16% | Upgrade
|
| Free Cash Flow | -575.35 | -532.27 | 378.15 | 3,203 | 634.16 | 77.77 | Upgrade
|
| Free Cash Flow Per Share | -0.44 | -0.40 | 0.30 | 2.56 | 0.52 | 0.07 | Upgrade
|
| Dividend Per Share | - | - | 0.320 | 0.714 | 0.099 | 0.088 | Upgrade
|
| Dividend Growth | - | - | -55.20% | 624.44% | 12.04% | - | Upgrade
|
| Gross Margin | 47.81% | 61.42% | 80.34% | 89.29% | 85.21% | 79.88% | Upgrade
|
| Operating Margin | -39.49% | -14.04% | 24.75% | 47.07% | 38.91% | 30.78% | Upgrade
|
| Profit Margin | -18.59% | 4.73% | 22.64% | 42.34% | 35.15% | 28.76% | Upgrade
|
| Free Cash Flow Margin | -32.04% | -23.71% | 6.86% | 28.63% | 11.03% | 3.30% | Upgrade
|
| EBITDA | -432.49 | -65.06 | 1,579 | 5,401 | 2,334 | 809.21 | Upgrade
|
| EBITDA Margin | -24.09% | -2.90% | 28.66% | 48.28% | 40.59% | 34.37% | Upgrade
|
| D&A For EBITDA | 276.58 | 250.31 | 215.29 | 136.17 | 96.2 | 84.47 | Upgrade
|
| EBIT | -709.07 | -315.37 | 1,364 | 5,265 | 2,238 | 724.74 | Upgrade
|
| EBIT Margin | -39.49% | -14.04% | 24.75% | 47.07% | 38.91% | 30.78% | Upgrade
|
| Effective Tax Rate | - | - | 10.54% | 12.89% | 10.54% | 10.81% | Upgrade
|
| Revenue as Reported | 1,796 | 2,245 | 5,511 | 11,185 | 5,750 | 2,354 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.